2024 Annual Meeting | C44 - Cutting-edge Neuro-rehabilitation

Date Sunday 04/14/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | 102/104/106

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) A. M. Barrett, MD, FAAN

Topic(s) Neuro-rehabilitation

Learning Objectives Participants will be able to identify spatial neglect, and the need for prism adaptation therapy, in stroke survivors; recognize applications of transcranial magnetic and electrical stimulation of the brain as novel interventions for neurologic cognitive deficits; comprehend and apply proven concepts in order to stand up a program providing noninvasive brain stimulation for depression and other neuropsychiatric conditions; and describe the range of restorative therapies available and identify approaches by which biomarkers can aid study design and results interpretation.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:10 PM MDT	Introduction	Welcome and Introduction A. M. Barrett, MD, FAAN
01:10 PM - 01:30 PM MDT	Speaker	Prism Adaptation Therapy for Spatial Neglect Rehabilitation A. M. Barrett, MD, FAAN
01:30 PM - 01:50 PM MDT	Speaker	Neuromodulation for Cognitive Rehabilitation: Mechanisms and Evidence Roy H. Hamilton, MD, MS, FAAN
01:50 PM - 02:10 PM MDT	Speaker	Neuromodulation in Neurology; Programs and Their Launch Daniel Press, MD
02:10 PM - 02:40 PM MDT	Speaker	Stroke Motor Recovery and Brain Repair Steven C. Cramer, MD, FAAN
02:40 PM - 03:10 PM MDT	Discussion	Questions, Answers, and Discussion A. M. Barrett, MD, FAAN, Roy H. Hamilton, MD, MS, FAAN, Daniel Press, MD, Steven C. Cramer, MD, FAAN

Faculty Disclosures
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD.
Roy H. Hamilton, MD, MS, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology (Journal). The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Daniel Press, MD	The institution of Dr. Press has received research support from NIH. The institution of Dr. Press has received research support from Biogen. The institution of Dr. Press has received research support from Janssen. Dr. Press has received publishing royalties from a publication relating to health care.
Steven C. Cramer, MD, FAAN	Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Constant Therapeutics, BrainQ, Myomo, MicroTransponder, Panaxium, Beren Therapeutics, Medtronic, Stream Biomedical, NeuroTrauma Sciences, and TRCare. . Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.